Wize Pharma

Wize Pharma FCF Growth

Delisted·Jan 10, 2019

The Year-over-Year Free Cash Flow Growth of Wize Pharma (WIZP) as of Nov 19, 2026 is 26.36 %. In the previous year, Year-over-Year Free Cash Flow Growth was 6.73 % — a change of 291.46% (higher).

FCF Growth

26.36 %

YoY

291.46%

Last updated:

Year-over-Year Free Cash Flow Growth of Wize Pharma is 2020 26.36 % . Year-over-Year Free Cash Flow Growth of Wize Pharma was 2019 6.73 % . It decreases by 291.46% higher compared to the previous year.

The Wize Pharma FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2015
-1,658.93 USD
Jan 1, 2016
55.58 USD
Jan 1, 2017
-56.34 USD
Jan 1, 2018
-61.77 USD
Jan 1, 2019
6.73 USD
Jan 1, 2020
26.36 USD
The Wize Pharma FCF Growth history
YEARFCF GrowthYoY
26.36 %+291.46%
6.73 %-110.90%
-61.77 %+9.63%
-56.34 %-201.37%
55.58 %-103.35%
-1,658.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Year-over-Year Free Cash Flow Growth of Wize Pharma is 26.36 % in 2020.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Wize Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Wize Pharma

All Key Metrics — Wize Pharma